Magnetic resonance imaging in rectal cancer: the MERCURY experience.
Eleven European clinics, well experienced in a multidisciplinary approach to rectal cancer therapy, were testing magnetic resonance imaging (MRI) as a preoperative tool for staging of unselected rectal cancer patients. Aims and preliminary results of the study are presented. The way of using MRI for patient selection for neoadjuvant therapy is demonstrated from Berlin-Friedrichshain.
Strassburg
J
J
Klinik für Chirurgie und Visceralchirurgie, Vivantes Klinikum im Friedrichshain, Landsberger Allee 49, D-10249 Berlin, Germany. Joachim.strassburg@vivantes.de
D005060:Europe; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis*; D009367:Neoplasm Staging; D011300:Preoperative Care / Q000379:methods; D011351:Proctoscopy / Q000379:methods; D011379:Prognosis; D012004:Rectal Neoplasms / Q000175:diagnosis* / Q000601:surgery*; D012007:Rectum / Q000473:pathology*; D012680:Sensitivity and Specificity